| A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma (NCT03254927) | Celldex Therapeutics | 2018-03-27 |
| Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee (NCT03485157) | MiMedx Group, Inc. | 2018-03-27 |
| Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers (NCT03403465) | Duke University | 2018-03-27 |
| A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer (NCT03512756) | Tyme, Inc | 2018-03-27 |
| TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms (NCT03503968) | Medigene AG | 2018-03-27 |
| Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL (NCT03379051) | TG Therapeutics, Inc. | 2018-03-27 |
| Cantharidin and Occlusion in Verruca Epithelium (NCT03487549) | Verrica Pharmaceuticals Inc. | 2018-03-27 |
| Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV) (NCT03365947) | Arrowhead Pharmaceuticals | 2018-03-27 |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer (NCT03501056) | Fuda Cancer Hospital, Guangzhou | 2018-03-27 |
| Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock (NCT03366220) | The University of Texas Health Science Center, Houston | 2018-03-26 |
| Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) (NCT03452527) | Iconic Therapeutics, Inc. | 2018-03-26 |
| Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors (NCT03360890) | University of Chicago | 2018-03-26 |
| A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS) (NCT03387046) | Merck KGaA, Darmstadt, Germany | 2018-03-26 |
| SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer (NCT03443492) | National Health Research Institutes, Taiwan | 2018-03-26 |
| A Phase II Study of BVD-523 in Metastatic Uveal Melanoma (NCT03417739) | Dana-Farber Cancer Institute | 2018-03-26 |
| Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia (NCT03254173) | Catherine Naseef Hunter | 2018-03-26 |
| A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants (NCT03486392) | Janssen Research & Development, LLC | 2018-03-26 |
| Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as First Line Chemotherapy in Gastric Cancer (MK-3475-659/KEYNOTE-659) (NCT03382600) | Merck Sharp & Dohme LLC | 2018-03-26 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout Attack (NCT04067492) | R-Pharm | 2018-03-26 |
| Ixazomib, ONC201, and Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT03492138) | Ajai Chari | 2018-03-26 |
| Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma (NCT03393936) | Shanghai PerHum Therapeutics Co., Ltd. | 2018-03-26 |
| FP-101 for the Treatment of Hot Flashes in Postmenopausal Women (NCT03285672) | Fervent Pharmaceuticals | 2018-03-26 |
| Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer (NCT03311750) | Hellenic Cooperative Oncology Group | 2018-03-26 |
| Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis (NCT03428711) | Quovadis Associazione | 2018-03-26 |
| Blood Pressure in Blacks and Calcium (BBC) and Vitamin D Study (NCT03070483) | Loyola University | 2018-03-25 |
| AXS-05 Phase II Trial on Smoking Behavior (NCT03471767) | James Davis | 2018-03-25 |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer (NCT03484962) | Fuda Cancer Hospital, Guangzhou | 2018-03-25 |
| Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC (NCT03289819) | Institut fuer Frauengesundheit | 2018-03-23 |
| Blood Pressure Lowering in Dialysis (BOLD) Trial (NCT03459807) | University of California, San Francisco | 2018-03-23 |
| Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (NCT03418038) | Mayo Clinic | 2018-03-23 |
| Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK) (NCT03430869) | Chang Gung Memorial Hospital | 2018-03-23 |
| Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) (NCT03297606) | Canadian Cancer Trials Group | 2018-03-23 |
| Palbociclib and Cetuximab in Metastatic Colorectal Cancer (NCT03446157) | UNC Lineberger Comprehensive Cancer Center | 2018-03-23 |
| Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer (NCT03087708) | Alliance for Clinical Trials in Oncology | 2018-03-23 |
| Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma (NCT03401853) | University of Washington | 2018-03-23 |
| Sentinel Lymph Node in Early Ovarian Cancer (NCT03452982) | Instituto de Investigacion Sanitaria La Fe | 2018-03-23 |
| PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease (NCT04052737) | Pharmazz, Inc. | 2018-03-23 |
| Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy (NCT03463161) | University of Chicago | 2018-03-23 |
| Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy (NCT03173638) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2018-03-23 |
| An Efficacy and Safety Study of Palovarotene for the Treatment of MO (NCT03442985) | Clementia Pharmaceuticals Inc. | 2018-03-22 |
| Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer (NCT04348032) | Chinese Academy of Medical Sciences | 2018-03-22 |
| Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy (NCT03062254) | Sir Mortimer B. Davis - Jewish General Hospital | 2018-03-22 |
| Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy (NCT03412396) | M.D. Anderson Cancer Center | 2018-03-22 |
| A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution (NCT03495817) | Aclaris Therapeutics, Inc. | 2018-03-22 |
| A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer (NCT03481998) | Jiangsu HengRui Medicine Co., Ltd. | 2018-03-22 |
| Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer (NCT03679338) | Institut Paoli-Calmettes | 2018-03-22 |
| Nutraceutical Efficacy for rUTI (NCT03395288) | Washington University School of Medicine | 2018-03-22 |
| Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC) (NCT03095612) | University of Texas Southwestern Medical Center | 2018-03-22 |
| Effectiveness of Botox on Reducing Rest Tremor in Parkinson's Disease (NCT03301272) | University of North Carolina, Chapel Hill | 2018-03-22 |
| A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) (NCT03395210) | Principia Biopharma, a Sanofi Company | 2018-03-22 |
| Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer (NCT03382912) | Eli Lilly and Company | 2018-03-22 |
| Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia (NCT02798367) | Ache Laboratorios Farmaceuticos S.A. | 2018-03-22 |
| The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy (NCT03457493) | University of Alabama at Birmingham | 2018-03-22 |
| A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208) (NCT03347123) | Incyte Corporation | 2018-03-21 |
| WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (NCT03297359) | Ottawa Hospital Research Institute | 2018-03-21 |
| Estradiol Pretreatment With Misoprostol in Second Trimester Miscarriage (NCT03479879) | Ain Shams University | 2018-03-21 |
| Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer (NCT03428126) | M.D. Anderson Cancer Center | 2018-03-21 |
| Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis (NCT03474198) | University College, London | 2018-03-21 |
| Study to Evaluate the Safety and Efficacy of Selonsertib, Firsocostat, Cilofexor, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (NCT03449446) | Gilead Sciences | 2018-03-21 |
| Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation (NCT03342196) | Case Comprehensive Cancer Center | 2018-03-21 |
| Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT03333746) | Yvonne Efebera | 2018-03-21 |
| Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients (NCT03359590) | Profil Institut für Stoffwechselforschung GmbH | 2018-03-21 |
| ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer (NCT03485729) | Jazz Pharmaceuticals | 2018-03-21 |
| Study of VX-121 in Healthy Subjects and in Subjects With Cystic Fibrosis (NCT03768089) | Vertex Pharmaceuticals Incorporated | 2018-03-20 |
| A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer. (NCT03906669) | St Vincent's Hospital | 2018-03-20 |
| Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease (NCT03854305) | Provention Bio, Inc. | 2018-03-20 |
| Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy (NCT03283371) | Biogen | 2018-03-20 |
| Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors (NCT03366103) | National Cancer Institute (NCI) | 2018-03-20 |
| Tolcapone in Obsessive Compulsive Disorder (NCT03348930) | University of Chicago | 2018-03-20 |
| Combination Immunotherapy in Biochemically Recurrent Prostate Cancer (NCT03315871) | National Cancer Institute (NCI) | 2018-03-20 |
| A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine (NCT03443427) | GlaxoSmithKline | 2018-03-20 |
| A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab (NCT03368859) | AbbVie | 2018-03-20 |
| Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (NCT03469531) | Zhujiang Hospital | 2018-03-20 |
| Efficacy and Safety of MMFS in Early AD (NCT03531684) | Neurocentria, Inc. | 2018-03-20 |
| Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer (NCT03456843) | Yale University | 2018-03-20 |
| Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients (NCT03383419) | Baylor Research Institute | 2018-03-20 |
| QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. (NCT03387085) | ImmunityBio, Inc. | 2018-03-19 |
| Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer (NCT03382899) | Eli Lilly and Company | 2018-03-19 |
| A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo (NCT03468855) | Aclaris Therapeutics, Inc. | 2018-03-19 |
| Fecal Microbiota Transplant (FMT) in Melanoma Patients (NCT03341143) | Zarour, Hassane, MD | 2018-03-19 |
| Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer (NCT03463889) | University of California, San Francisco | 2018-03-19 |
| Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies (NCT03471260) | M.D. Anderson Cancer Center | 2018-03-19 |
| Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer (NCT03436485) | Orion Corporation, Orion Pharma | 2018-03-19 |
| Reducing Knee Compression When Sleeping in Those With Knee OA (NCT04188054) | University of Bradford | 2018-03-19 |
| Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17) (NCT03490331) | Holostem s.r.l. | 2018-03-19 |
| Tolerability and Acceptability of Fibersol-2 in Children (NCT03565393) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2018-03-19 |
| STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units (NCT03385928) | Neuroscience Trials Australia | 2018-03-19 |
| Safety, Tolerability and Pharmacodynamics of SYNB1020 (NCT03447730) | Synlogic | 2018-03-19 |
| Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia (NCT03373435) | Eiger BioPharmaceuticals | 2018-03-19 |
| Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis (NCT02315898) | University of Michigan | 2018-03-19 |
| Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression. (NCT03265808) | Ihsan M Salloum, MD, MPH | 2018-03-18 |
| Prospective Study of Short Course Radiation Therapy Followed by Neoadjuvant Chemotherapy and Surgery in Locally Advanced Rectal Cancer (NCT05622357) | National Cancer Institute, Egypt | 2018-03-18 |
| Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock (NCT03380507) | Hamad Medical Corporation | 2018-03-17 |
| Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma (NCT03700450) | Universitätsklinikum Hamburg-Eppendorf | 2018-03-16 |
| Personalized Treatment Algorithms for Difficult-to-treat Asthma (NCT04179461) | Children's Hospital Medical Center, Cincinnati | 2018-03-16 |
| Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma (NCT03409432) | John Reneau | 2018-03-16 |
| Study of Gefapixant (MK-7264) in Adult Japanese Participants With Unexplained or Refractory Chronic Cough (MK-7264-033) (NCT03482713) | Merck Sharp & Dohme LLC | 2018-03-16 |
| Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. (NCT03314636) | Oslo University Hospital | 2018-03-16 |
| "Unifuzol®" in Patients With Peripheral Arterial Disease (NCT03861416) | POLYSAN Scientific & Technological Pharmaceutical Company | 2018-03-16 |
| TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid (NCT03397173) | Case Comprehensive Cancer Center | 2018-03-16 |